featured
Relapses of Infantile Hemangioma Reduced With Long-Term Oral Propranolol
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Treatment Options for Infantile Hemangiomas
- Factors Associated With Propanolol-Treated Infantile Hemangioma Relapse
- Twenty-Four Hour Hospitalization for Patients Initiating Systemic Propranolol Therapy for Infantile Hemangiomas-Is It Indicated?
- Cardiac Screening Before Propranolol in Infants With Hemangiomas
- Is Cardiovascular Evaluation Necessary Prior to and During Beta-Blocker Therapy for Infantile Hemangiomas?
- Effectiveness of Propranolol in Infantile Hemangioma Beyond the Proliferation Phase
Disclosure statements are available on the authors' profiles:
Pediatric Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Treatment With Oral Propranolol Reduces Relapses of Infantile Hemangiomas
Pediatr Dermatol 2014 Jan 01;31(1)14-20, A Giachetti, R Garcia-Monaco, M Sojo, MF Scacchi, C Cernadas, M Guerchicoff Lemcke, F DovasioFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.